Matthew Breen
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (18)
Year:
2026
Year:
2026
Background Polypoid cystitis (PoC) in dogs is associated with chronic inflammatory bladder conditions and is discovered during evaluation for signs of lower urinary tract disease, or incidentally. Objective To describe PoC in dogs evaluated in an academic practice. Animals Dogs with confirmed (n = 59) or presumptive (n = 53) PoC were evaluated between January 2004 and October 2020. Methods For this retrospective study, medical records were searched for PoC. Results The most common presenting signs of 112 dogs with PoC were hematuria (n = 42; 38%), stranguria (n = 28; 25%), and pollakiuria (n = 25; 22%). Polyps were found incidentally (n = 13; 12%). Urinary tract infection (UTI; n = 61; 54%) or urolithiasis (n = 38; 34%) was a common presumptive cause. Escherichia coli (n = 39; 53%), Enterococcus faecalis (n = 14; 19%) and Staphylococcus pseudintermedius (n = 5; 7%) were isolated from dogs with UTI. Ultrasonographic findings (n = 101) included polypoid structures (n = 44; 44%), broad-based masses (n = 16; 26%), and bladder wall thickening (n = 25; 25%); mostly in the cranioventral bladder apex (n = 56; 80%). Of 41 specimens tested, none had evidence of the BRAF V595E mutation. Urinary tract neoplasia was not reported in any dog during follow-up (range 1 month–8.4 years; median 8 months). Interventions included antibiotic or anti-inflammatory administration, and surgical or cystoscopic ablation. During follow-up, recurrent signs of lower urinary tract disease were reported in 23 (20%) dogs. Conclusions and Clinical Importance History of either UTI or urolithiasis, compatible imaging findings, and absence of detectable BRAF V595E mutation support the presumptive diagnosis of PoC in dogs. Affected dogs have a good prognosis, warranting differentiation from other urinary tract diseases.
Year:
2025
Parchment is a writing surface derived from animal skins. While sequencing the mitochondrial genome has been used to identify the parchment animal source, non-destructive sampling methods are pivotal because of their unique and irreplaceable nature. In this study, four different parchments were utilized to evaluate three non-destructive sampling methods: brushing, gecko tape, and forensic fibre lifts. For all methods, the impact of a 30-second eraser pre-cleaning to remove surface contaminants was assessed. After sample collection, total DNA was isolated, the mitochondrial genome enriched and sequenced using Illumina chemistry, and sequencing reads processed through a bioinformatics pipeline. Across all four documents, brushing with an eraser pre-cleaning was the optimal method, with an average of 98% of the mitochondrial genome recovered. Regardless of sampling method, collection after a 30-second eraser pre-cleaning resulted in higher source species DNA sequences. Non-destructive sampling will preserve documents with historical significance while allowing for genetic analysis.
Year:
2025
The relationships between gut microbiota and animal health are an important consideration increasingly influential in the management of wild and ex situ endangered species, such as the cheetah ( Acinonyx jubatus ). To better understand these relationships, fresh fecal samples are currently required as a non-invasive alternative for the gut microbiome. Unfortunately, fresh samples are challenging to collect in the wild. This study had two aims: 1) to determine the optimal collection time point for cheetah feces after deposit in their native environment of Namibia as a guide for wild cheetah fecal microbiome studies; and 2) to compare the fecal microbiota of two ex situ cheetah populations (Front Royal, VA, USA and Otjiwarongo, Namibia), which also consume different diets. We collected eight fresh fecal samples from cheetahs in Namibia and allowed them to decompose for four days, taking subsamples each day. The fresh Namibian samples (n = 8) were also used in objective two for comparison to fresh USA cheetah samples (n = 8). All samples were analyzed for bacterial community diversity and composition using 16S rRNA gene amplicon sequencing. First, over a five-day sampling period in Namibia, subsamples 1-3 days post-fresh showed no changes in bacterial diversity or composition compared to fresh subsamples. Second, fresh ex situ cheetah samples under Namibian conditions had increased bacterial taxa, more phylogenetically diverse bacterial communities, and compositionally distinct microbiomes from cheetahs managed in human care in the USA. However, when bacterial ASVs were weighted by relative abundance, both populations shared 69% of their total bacterial sequences indicating a conserved cheetah microbiota between the two populations. We also found few differences in predictive functions of the fecal microbiota between the populations, where only one disease-related pathway was higher in the USA samples. Overall, our findings suggest that in dry season conditions (no recorded rainfall) in Namibia, fecals may be usable for up to three days after defecation for microbial ecology studies. There are significant differences between ex situ Namibian and USA populations, and we suggest further investigation into the influence of diet, host demographics, and environment on the gut microbiota and health of cheetahs.
Year:
2025
Hematopoietic expansion derived from adoptive transplantation of canine hemangiosarcoma in immunodeficient mice. A and B , Xenotransplantation of canine hemangiosarcoma cell lines created exuberant myeloid hyperplasia in mouse spleens. Representative photomicrographs show histopathology by H&E staining of spleens from NSG mice transplanted with hemangiosarcoma cell lines SB (A) and EFB (B). C, Immunoreactivity of anti-mouse Ki-67 (Tec-3) antibody shows strongly positive signal in proliferating cells in the spleen. D, Immunostaining of anti-human (and canine cross-reactive) Ki-67 (MiB-1) antibody shows lack of positive staining among proliferating cells. E, The proliferating cells are immunoreactive with anti-mouse Ter-119 antibody. F, SB cells expressing Luciferase are detected in mouse spleen (arrows). Images shown in C, D, E, and F are from IHC staining done in mice inoculated with SB cells modified to express GFP and firefly Luciferase. Horseradish peroxidase (for Ki-67 stains) and alkaline phosphatase (for Ter-119 and Luciferase) conjugates were used. Counterstain = hematoxylin. A–D: Bar = 200 µm; E–F: Bar = 50 µm.
Year:
2024
Hemangiosarcoma and angiosarcoma are soft-tissue sarcomas of blood vessel–forming cells in dogs and humans, respectively. These vasoformative sarcomas are aggressive and highly metastatic, with disorganized, irregular blood-filled vascular spaces. Our objective was to define molecular programs which support the niche that enables progression of canine hemangiosarcoma and human angiosarcoma. Dog-in-mouse hemangiosarcoma xenografts recapitulated the vasoformative and highly angiogenic morphology and molecular characteristics of primary tumors. Blood vessels in the tumors were complex and disorganized, and they were lined by both donor and host cells. In a series of xenografts, we observed that the transplanted hemangiosarcoma cells created exuberant myeloid hyperplasia and gave rise to lymphoproliferative tumors of mouse origin. Our functional analyses indicate that hemangiosarcoma cells generate a microenvironment that supports expansion and differentiation of hematopoietic progenitor populations. Furthermore, gene expression profiling data revealed hemangiosarcoma cells expressed a repertoire of hematopoietic cytokines capable of regulating the surrounding stromal cells. We conclude that canine hemangiosarcomas, and possibly human angiosarcomas, maintain molecular properties that provide hematopoietic support and facilitate stromal reactions, suggesting their potential involvement in promoting the growth of hematopoietic tumors. Significance: We demonstrate that hemangiosarcomas regulate molecular programs supporting hematopoietic expansion and differentiation, providing insights into their potential roles in creating a permissive stromal-immune environment for tumor progression.
Year:
2024
Hematopoietic support and stromal regulation of canine hemangiosarcoma cells. A, Flow cytometric data depict populations of cells expressing CD43 and CD45 differentiated from CD34 + hUCB cells. CD34 + hUCB cells were pooled from 2 patients. M2-10B4, hBM-MSCs, and canine hemangiosarcoma cells (DHSA-1426 and EFB) were seeded on gelatin-coated 24-well plates at a density of 1 × 10 5 cells/well. Gelatin-coated wells without stroma served as a negative control. Surface antigens CD34, CD43, and CD45 were analyzed at week 5. B and C , Bar graphs illustrate number of different colonies formed by hUCB CD34 + cells cocultured with feeder cells. Both DHSA-1426 and EFB canine hemangiosarcoma cell lines expanded hUCB CD34 + cells similarly to the M2-10B4 and hBM-MSC positive control lines, while gelatin-coated wells alone failed to support expansion. Burst-forming unit-erythroid (BFU-E), CFU (colony-forming unit)-Erythroid (CFU-E), CFU-granulocyte/macrophage (CFU-GM), CFU-macrophage (CFU-M), and CFU-granulocyte/erythroid/macrophage/megakaryocyte (CFU-GEMM) were determined for CFU assay.
Year:
2024
Hemangiosarcoma and angiosarcoma are soft-tissue sarcomas of blood vessel–forming cells in dogs and humans, respectively. These vasoformative sarcomas are aggressive and highly metastatic, with disorganized, irregular blood-filled vascular spaces. Our objective was to define molecular programs which support the niche that enables progression of canine hemangiosarcoma and human angiosarcoma. Dog-in-mouse hemangiosarcoma xenografts recapitulated the vasoformative and highly angiogenic morphology and molecular characteristics of primary tumors. Blood vessels in the tumors were complex and disorganized, and they were lined by both donor and host cells. In a series of xenografts, we observed that the transplanted hemangiosarcoma cells created exuberant myeloid hyperplasia and gave rise to lymphoproliferative tumors of mouse origin. Our functional analyses indicate that hemangiosarcoma cells generate a microenvironment that supports expansion and differentiation of hematopoietic progenitor populations. Furthermore, gene expression profiling data revealed hemangiosarcoma cells expressed a repertoire of hematopoietic cytokines capable of regulating the surrounding stromal cells. We conclude that canine hemangiosarcomas, and possibly human angiosarcomas, maintain molecular properties that provide hematopoietic support and facilitate stromal reactions, suggesting their potential involvement in promoting the growth of hematopoietic tumors. Significance: We demonstrate that hemangiosarcomas regulate molecular programs supporting hematopoietic expansion and differentiation, providing insights into their potential roles in creating a permissive stromal-immune environment for tumor progression.
Year:
2024
Gene expression analysis in DHSA-1426 hemangiosarcoma cells and xenograft tumors using RNA-seq data. A, The volcano plot visualizes 2,391 significant DEGs (1,034 upregulated and 1,357 downregulated) in DHSA-1426 cells ( n = 3) compared with nonmalignant endothelial cells ( n = 4; q -value 2 fold change > |2|). The DEGs are indicated by red dots. NS = not significant; log 2 FC = log 2 fold change. B, Gene Ontology enrichment analysis depicts biological processes associated with significant DEGs. P , adjust = adjusted P -value. C, Bar graphs present normalized gene expression values of CSF3 , IL6 , and IL8 in RNA-seq data generated from canine nonmalignant endothelial cells ( n = 4) and DHSA-1426 hemangiosarcoma cells ( n = 3). D, Schematic illustration visualizes the experimental steps for species-specific gene expression analysis of xenograft tumors using RNA-seq data. E, Bar graphs show the expression of mouse-specific genes in RNA-seq data generated from xenograft tumor tissues of canine hemangiosarcoma ( n = 4) and mouse lymphoma ( n = 7). A two-way ANOVA test was conducted to compare the means between groups. ****, P
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2022
Collaborators (16)
Jong Hyuk Kim
Assistant Professor
University of Florida
Troy C. Lund
University of Minnesota
Shelly Vaden
Professor, Nephrology/Urology
North Carolina State University
Sagar M. Goyal
University of Minnesota
Jaime F. Modiano
Alvin & June Perlman Professor of Animal Oncology
University of Minnesota
Timothy O'Brien
Professor
University of Minnesota
Susan Bullman
Associate Professor
Fred Hutchinson Cancer Research Center
Timothy Stinson
Associate Professor
North Carolina State University
Kelly A Meiklejohn
Associate Professor of Forensic Science
University of Western Sydney
Norman Kleiman
Associate Professor
Columbia University
Ashley Schulte
University of Minnesota
Sunil Kumar Mor
Assistant Professor
South Dakota State University
DONGHEE LEE
University of Florida
Dan Kaufman
Professor
University of California, San Diego
Timothy Mousseau
Professor
University of South Carolina
Matthew Meyerson
Director, Center for Cancer Genomics
Dana-Farber Cancer Institute
Make your next move.
Prepare your application
Review drafts before you send them.